| |
|
|
|
Vaccinex Inc  
|
|
2.14 -0.1 (-0.04%) |
09-28 16:00 |
|
Open: |
2.22 |
Pre close: |
2.24 |
Target:
|
2.77
|
|
High: |
2.2397 |
Low: |
2.12 |
Resistance:
|
2.37
2.53
|
|
Volume: |
95,163 |
Market Cap: |
66M |
Support:
|
2.11
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.21
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.29 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.42 |
Stochastic Oscillator |
%K(14,3):
|
29.67 |
|
MA(250): |
2.48  |
%D(3): |
32.82 |
|
Average Volume(K) |
3-Month: |
449030
|
52-Week |
High:
|
9.56 |
|
10-Days: |
8266 |
Low: |
1.64 |
|
RSI |
RSI(14):
|
37.57 |
Change(%): |
20.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.341 |
Return on Equity (ttm) |
-268.8 |
Shares Out. (M) |
28.45 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-96.3 |
Shares Float (M) |
15.48 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.49 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
36.27 |
|
Forward EPS |
-5.650 |
Gross Profit (p.s.) |
-0.736 |
Shares Short (K) |
913 |
|
Book Value (p.s.) |
0.030 |
EBITDA (p.s.) |
-0.953 |
P/E |
-1.60 |
|
Sales Per Share |
0.052 |
Qtrly Earnings Growth |
0.00 |
P/BV |
71.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.25 |
P/S |
41.14 |
|
Operating Margin |
-1858.44 |
Levered Free Cash Flow
(M) |
-18.05 |
P/CF |
-2.16 |
|
|
|
|
|
|
